MERSANA THERAPEUTICS INC. - COMMON STOCK
0.6433
24-1月-25 16:45:00
15 分の遅延
株式
+0.1229
+23.62%
本日の幅
0.5204 - 0.6890
ISIN
N/A
ソース
NASDAQ
-
Mersana Therapeutics Announces Changes in Leadership
06 9 2023 07:00:40 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 8 2023 16:05:52 提供 Nasdaq GlobeNewswire
-
27 7 2023 07:06:23 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 6 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 6 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 5 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 5 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023
02 5 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting
26 4 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 4 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
13 3 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Statement About SVB
10 3 2023 19:10:38 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023
21 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 2 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
02 2 2023 08:00:01 提供 Nasdaq GlobeNewswire